Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibodies in Drug Discovery

Eugene Zhukovsky's Biography

Eugene Zhukovsky, Chief Scientific Officer, Biomunex Pharmaceuticals

Since January 2015 Dr. Zhukovsky is the Chief Scientific Officer of Biomunex Pharmaceuticals, where he is developing BiXAb® bispecific antibodies for immune-oncology. He has over two decades of professional experience in the field of biotherapeutics research and development. Before joining Biomunex, he served as the CSO of Affimed Therapeutics; there he was responsible for the advancement of candidate therapeutics from discovery to the clinic and novel technology development. Prior to that he was a Senior Research Fellow in the Biotherapeutics Department at Boehringer Ingelheim Pharmaceuticals, Inc. leading antibody discovery efforts. Prior to that Dr. Zhukovsky was an Associate Director at Xencor, Inc. where he led translational research efforts resulting in several clinical candidates for hematological malignancies. Dr. Zhukovsky began his professional career employing phage display technology at Neurex Corporation before moving to Lynx Therapeutics (now Illumina, Inc.) to work on the development of genomics technologies. Dr. Zhukovsky performed a postdoctoral fellowship at Genentech, Inc. He received a PhD in biochemistry from Brandeis University.

Eugene Zhukovsky Image

BiXAb(R) is a Versatile Modular Platform for the Development of Bispecific Antibodies

Monday, 6 March 2017 at 15:15

Add to Calendar ▼2017-03-06 08:59:002017-03-06 09:59:00Europe/LondonSession

Plug-and Play BiXAb® platform enables generically applicable bispecific antibody design from any pair of monospecific mAbs. These bispecific antibodies possess excellent manufacturability, superior drug-like properties, and potent activity in vivo models. We will discuss a case study of the BiXAb® for the treatment of EGFR+/HER2+ solid tumors.

Session 1

Monday, 6 March 2017 at 08:59

Add to Calendar ▼2017-03-06 08:59:002017-03-06 09:59:00Europe/LondonSession

Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonAntibodies in Drug